234 related articles for article (PubMed ID: 2858584)
1. Comparison of the cardiovascular actions of dopamine and epinine in the dog.
Itoh H; Kohli JD; Rajfer SI; Goldberg LI
J Pharmacol Exp Ther; 1985 Apr; 233(1):87-93. PubMed ID: 2858584
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of the novel inotropic agent, ibopamine, with epinine, dopamine and fenoldopam on renal vascular dopamine receptors in the anesthetized dog.
Nichols AJ; Smith JM; Shebuski RJ; Ruffolo RR
J Pharmacol Exp Ther; 1987 Aug; 242(2):573-8. PubMed ID: 2886644
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the alpha adrenoceptor activity of dopamine, ibopamine and epinine in the pulmonary circulation of the dog.
Shebuski RJ; Fujita T; Smith JM; Ruffolo RR
J Pharmacol Exp Ther; 1987 Apr; 241(1):6-12. PubMed ID: 3033210
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the alpha and beta adrenoceptor-mediated activities of the novel, orally active inotropic agent, ibopamine, in the cardiovascular system of the pithed rat: comparison with epinine and dopamine.
Nichols AJ; Ruffolo RR
J Pharmacol Exp Ther; 1987 Aug; 242(2):455-63. PubMed ID: 3039117
[TBL] [Abstract][Full Text] [Related]
5. Consistent unmasking of dopamine-induced dilation of the canine femoral vascular bed.
Listinsky JJ; Kohli JD; Goldberg LI
J Pharmacol Exp Ther; 1980 Dec; 215(3):662-7. PubMed ID: 6108364
[TBL] [Abstract][Full Text] [Related]
6. Systemic and coronary hemodynamic actions of the novel inotropic agent, ibopamine, and the de-esterified metabolite and active form, epinine: relationship to left ventricular performance in the dog.
Kopia GA; Ohlstein EH; Ruffolo RR
J Pharmacol Exp Ther; 1988 Aug; 246(2):434-40. PubMed ID: 3404441
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part I: Respiratory and cardiovascular systems.
Hirohashi M; Takasuna K; Yamashita N; Tamura K
Arzneimittelforschung; 1991 Jan; 41(1):9-18. PubMed ID: 1675573
[TBL] [Abstract][Full Text] [Related]
8. Dose-dependent separation of dopaminergic and adrenergic effects of epinine in healthy volunteers.
Daul A; Elter-Schulz M; Poller U; Jockenhövel F; Pönicke K; Boomsma F; Man in't Veld AJ; Schäfes RF; Brodde OE
Naunyn Schmiedebergs Arch Pharmacol; 1995 Oct; 352(4):429-37. PubMed ID: 8532072
[TBL] [Abstract][Full Text] [Related]
9. Effects of cerebroventricular administration of ouabain on renal hemodynamics in anesthetized dogs: evidence for the participation of renal dopaminergic vasodilator fibers.
Hom GJ; Jandhyala BS
J Pharmacol Exp Ther; 1984 Aug; 230(2):275-83. PubMed ID: 6747837
[TBL] [Abstract][Full Text] [Related]
10. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
[TBL] [Abstract][Full Text] [Related]
11. Effect of ibopamine on diuresis and arterial blood pressure in anesthetized rats and its interactions with dopaminergic and alpha- and beta-adrenergic antagonists.
Ferrini R; Miragoli G
Arzneimittelforschung; 1986 Feb; 36(2A):323-6. PubMed ID: 2871844
[TBL] [Abstract][Full Text] [Related]
12. Effects of ring fluorination on the cardiovascular actions of dopamine and norepinephrine in the dog.
Goldberg LI; Kohli JD; Cantacuzene D; Kirk KL; Creveling CR
J Pharmacol Exp Ther; 1980 Jun; 213(3):509-13. PubMed ID: 6894165
[TBL] [Abstract][Full Text] [Related]
13. N,N-Di-n-propyl dopamine: a qualitatively different dopamine vascular agonist.
Kohli JD; Goldberg LI; Volkman PH; Cannon JG
J Pharmacol Exp Ther; 1978 Oct; 207(1):16-22. PubMed ID: 702336
[TBL] [Abstract][Full Text] [Related]
14. Differential cardiovascular and neuroendocrine effects of epinine and dopamine in conscious pigs before and after adrenoceptor blockade.
van Woerkens LJ; Boomsma F; Man in 't Veld AJ; Bevers MM; Verdouw PD
Br J Pharmacol; 1992 Oct; 107(2):303-10. PubMed ID: 1330172
[TBL] [Abstract][Full Text] [Related]
15. The combined effects of dopamine (DA) and the DA antagonists EGYT-2509, chlorpromazine and haloperidol on the kidney function.
Kövér G; Fekete M; Tost H; Szemerédi K
Acta Physiol Hung; 1988; 72(3-4):321-33. PubMed ID: 3250211
[TBL] [Abstract][Full Text] [Related]
16. The effects of epinine on arterial blood pressure and regional vascular resistances in anesthetized rats.
Martínez-Mir I; Palop V; Morales-Olivas FJ; Estañ L; Rubio E
Gen Pharmacol; 1998 Jul; 31(1):75-9. PubMed ID: 9595283
[TBL] [Abstract][Full Text] [Related]
17. Systemic hemodynamic and regional blood flow effects of LY141865, a selective dopamine receptor agonist.
Hahn RA; MacDonald BR
J Pharmacol Exp Ther; 1984 Sep; 230(3):558-68. PubMed ID: 6470973
[TBL] [Abstract][Full Text] [Related]
18. The cardiovascular actions of dopamine and the effects of central and peripheral catecholaminergic receptor blocking drugs.
Setler PE; Pendleton RG; Finlay E
J Pharmacol Exp Ther; 1975 Mar; 192(3):702-12. PubMed ID: 1120964
[TBL] [Abstract][Full Text] [Related]
19. Effects of alpha adrenoceptor and dopamine receptor agonists and antagonists on ganglionic transmission.
Satoh Y; Kohli JD; Goldberg LI
J Pharmacol Exp Ther; 1989 Oct; 251(1):253-7. PubMed ID: 2571718
[TBL] [Abstract][Full Text] [Related]
20. Effect of dopamine, ibopamine, and epinine on alpha- and beta-adrenoceptors in canine pulmonary circulation.
Shebuski RJ; Smith JM; Ruffolo R
Fundam Clin Pharmacol; 1989; 3(3):211-21. PubMed ID: 2548941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
